Yposkesi enters into agreement in principle for strategic partnership with Axovant to expand Axovant’s gene therapy manufacturing capacity

Yposkesi enters into agreement in principle for strategic partnership with Axovant to expand Axovant’s gene therapy...

Corbeil-Essonnes, France, November 28, 2018 – Yposkesi, a leading CDMO for gene therapy viral vector manufacturing, today announces an agreement…